2D	two-dimensional
3D	three-dimensional
5-FU	5-fluorouracil
18F-FDG PET	Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography
ACS	acute coronary syndromes
AF	atrial fibrillation
ATP	adenosine triphosphate
BNP	B-type natriuretic peptide
CAD	coronary artery disease
CAR-T	Chimeric antigen receptor T cell
CCS	chronic coronary syndromes
CCT	cardiac computed tomography
CCTA	Coronary computed tomography angiography
CMR	cardiac magnetic resonance
CTA	computed tomography angiography
cTn	cardiac troponins
CTRCD	cancer therapy related cardiac dysfunction
CTR-CTV	cancer therapy-related cardiovascular toxicity
CV	cardiovascular
CVD	cardiovascular diseases
DUS	duplex ultrasound
EDV	end-diastolic volume
EGFR	Epidermal Growth Factor Receptor
ESV	end-systolic volume
ERK	extracellular signal-regulated kinase
FAC	fractional area change
GCS	global circumferential strain
GLS	global longitudinal strain
HER2	human epidermal growth factor receptor 2
HER2i	HER2 inhibitors
HF	heart failure
hs-cTn	high sensitivity cardiac troponin
hs-cTnI	high sensitivity cardiac troponin I
hs-cTnT	high sensitivity cardiac troponin T
HTN	systemic arterial hypertension
ICI	immune checkpoint inhibitors
IVC	inferior vena cava
LV	left ventricular
LVEF	left ventricular ejection fraction
LVD	left ventricular dysfunction
MI	myocardial infarction
MUGA	multigated acquisition
NPs	natriuretic peptides
NT-proBNP	N-terminal pro-B-type natriuretic peptide
PAD	peripheral artery disease
PE	pulmonary embolism
PH	pulmonary hypertension
PI	proteasome inhibitors
ROS	reactive oxygen species
RV	right ventricular
RVEF	right ventricular ejection fraction
TAPSE	tricuspid annular plane systolic excursion
TEE	transesophageal echocardiography
TKIs	small molecule tyrosine kinase inhibitors
TIL	tumor-infiltrating lymphocytes
TR	tricuspid regurgitation
TTE	transthoracic echocardiography
TTS	Takotsubo syndrome
VEGF	vascular endothelial growth factor
VEGFi	vascular endothelial growth factor inhibitors
VHD	valvular heart disease
VTE	venous thrombosis and venous thromboembolism